Drug Shortage Report for GLN-URSODIOL
| Report ID | 252092 |
| Drug Identification Number | 02426900 |
| Brand name | GLN-URSODIOL |
| Common or Proper name | GLN-Ursodiol |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | URSODIOL |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 tablets |
| ATC code | A05AA |
| ATC description | BILE THERAPY |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-11-11 |
| Actual start date | |
| Estimated end date | 2025-03-31 |
| Actual end date | 2025-03-11 |
| Shortage status | Resolved |
| Updated date | 2025-03-12 |
| Company comments | This product is being allocated at the customer level. This may result in shortages in certain locations. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-03-12 | English | Compare |
| v4 | 2025-03-11 | French | Compare |
| v3 | 2025-03-11 | English | Compare |
| v2 | 2025-03-06 | French | Compare |
| v1 | 2025-03-06 | English | Compare |
Showing 1 to 5 of 5